Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cardiovascular Drugs and Therapy
Published in: Cardiovascular Drugs and Therapy 5/2016

01-10-2016 | ACKNOWLEDGEMENTS

Reviewers for Cardiovascular Drugs and Therapy in 2015

Author: ᅟ ᅟ

Published in: Cardiovascular Drugs and Therapy | Issue 5/2016

Login to get access

Excerpt

The Editors-in-Chief of Cardiovascular Drugs and Therapy wish to thank all the reviewers who have taken time from their busy schedules to contribute to the peer review process. Every year, the top five reviewers will receive a 1-year subscription to the journal for themselves or the colleague of their choice.The reviewers are listed in alphabetical order: …
Metadata
Title
Reviewers for Cardiovascular Drugs and Therapy in 2015
Author
ᅟ ᅟ
Publication date
01-10-2016
Publisher
Springer US
Published in
Cardiovascular Drugs and Therapy / Issue 5/2016
Print ISSN: 0920-3206
Electronic ISSN: 1573-7241
DOI
https://doi.org/10.1007/s10557-016-6688-8

Other articles of this Issue 5/2016

Cardiovascular Drugs and Therapy 5/2016 Go to the issue

EDITORIAL

PCSK9: the Critical Role of Familial Hypercholesterolemia from Discovery to Benefit for all

REVIEW ARTICLE

Insulin in Acute Coronary Syndrome: a Narrative Review with Contemporary Perspectives

ORIGINAL ARTICLE

Amiodarone Compared with Lidocaine for Out-Of-Hospital Cardiac Arrest with Refractory Ventricular Fibrillation on Hospital Arrival: a Nationwide Database Study

ORIGINAL ARTICLE

Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia and LDL-C of 160 mg/dl or Higher

ORIGINAL ARTICLE

Algorithms to Identify Statin Intolerance in Medicare Administrative Claim Data

OriginalPaper

Prevention of Contrast-Induced Acute Kidney Injury: an Update

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits